Increased levels of ε and γ isoforms of 14-3-3 proteins in cerebrospinal fluid in patients with Creutzfeldt-Jakob disease

Clinical and Diagnostic Laboratory Immunology

Volumn 6, Issue 6, 1999, Pages 983-985

  Takahashi, Hidehiro ^a   Iwata, Toshinari ^a   Kitagawa, Yoshinori ^a   Takahashi, Reisuke H ^a   Sato, Yuko ^a   Wakabayashi, Hideki ^b   Takashima, Miwa ^b   Kido, Hiroshi ^b   Nagashima, Kazuo ^c,d   Kenney, Kimbra ^e   Gibbs Jr , Clarence J ^e   Kurata, Takeshi ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN DERIVATIVE; DIAGNOSTIC AGENT; PROTEIN; PROTEIN 14 3 3; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY AFFINITY; ANTIBODY DETECTION; ANTIGEN DETECTION; ANTIGEN RECOGNITION; ARTICLE; CELL LINE; CEREBROSPINAL FLUID; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; FEMALE; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; ANTIBODY SPECIFICITY; CHEMISTRY; HUMAN; HYBRIDOMA; IMMUNOLOGY; ISOMERISM; METABOLISM;

14-3-3 PROTEINS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CREUTZFELDT-JAKOB SYNDROME; HUMANS; HYBRIDOMAS; IMMUNOBLOTTING; ISOMERISM; PROTEINS; TYROSINE 3-MONOOXYGENASE;

EID: 0032585928     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.6.6.983-985.1999     Document Type: Article

References (12)

1. Collinge, J., K. C. Sidle, J. Meads, J. Ironside, and A. F. Hill. 1996. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383:685-690.
2. Gajdusek, D. C. 1996. Infectious amyloids: subacute spongiform encephalopathies as transmissible cerebral amyloidosis. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 2. Lippincott-Raven, Philadelphia, Pa.
3. Harrington, M. G., C. R. Meriril, D. M. Asher, and D. C. Gajdusek. 1986. Abnormal proteins in the cerebrosipinal fluid of patients with Creutzfeldt-Jakob disease. N. Engl. J. Med. 315:279-283.
4. Hsich, G., K. Kenney, C. J. Gibbs, K. H. Lee, and M. G. Harrington. 1996. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N. Engl. J. Med. 335:924-930.
5. Leffers, H., P. Madsen, H. H. Rasmussen, B. Honore, A. H. Andersen, E. Walbum, J. Vandekerckhove, and J. E. Celis. 1993. Molecular cloning and expression of the transformation sensitive epithelial marker stratifin. A member of a protein family that has been involved in the protein kinase C signaling pathway. J. Mol. Biol. 231:982-998.
6. Morrison, D. 1994. 14-3-3: modulators of signaling proteins? Science 266: 56-57.
7. Tzivion, G., Z. Luo, and J. Avruch. 1998. A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity. Nature 394:88-92.
8. Weber, T., M. Otto, M. Bodemer, and I. Zerr. 1997. Diagnosis of Creutzteldt-Jakob disease and related human spongiform encephalopathies. Biomed. Pharmacother. 51:381-387.
9. Wells, G. A., A. C. Scott, C. T. Johnson, R. F. Gunning, R. D. Hancock, M. Jeffrey, M. Dawson, and R. Bradley. 1987. A novel progressive spongiform encephalopathy in cattle. Vet. Rec. 121:419-420.
10. Will, R. G., J. W. Ironside, M. Zeidler, S. N. Cousens, K. Estibeiro, Alperovitch, A., S. Poser, M. Pocchiari, A. Hofman, and P. G. Smith. 1996. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921-925.
11. Zerr, I., M. Bodemer, M. Otto, S. Poser, O. Windl, H. A. Kretzschmar, O. Gefeller, and T. Weber. 1996. Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid. Lancet 348:846-849.
12. Zerr, I., M. Bodemer, and T. Weber. 1997. The 14-3-3 brain protein and transmissible spongiform encephalopathy. N. Engl. J. Med. 336:874.